Prolonged Grief Disorder Clinical Trial
Official title:
LIVIA 2.0: A Randomized Controlled Trial of Two French Internet Intervention for Adults Struggling With Prolonged Grief Symptoms After the Loss of a Close One (by Bereavement or Separation/Divorce)
NCT number | NCT05219760 |
Other study ID # | 2021-D0086 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 6, 2022 |
Est. completion date | August 10, 2023 |
Verified date | September 2023 |
Source | University of Lausanne |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial (RCT). More specifically, the investigators will test the following primary hypotheses: - Both interventions will significantly increase participants' well-being and decrease their distress, and those changes will be stable until follow-up. - LIVIA 2.0 will be more efficient than LIVIA 1 on all measure outcomes. - LIVIA 2.0 will have less dropouts than LIVIA 1.
Status | Completed |
Enrollment | 64 |
Est. completion date | August 10, 2023 |
Est. primary completion date | January 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Bereavement or separation/divorce - Either of these events should have happened more than 6 months before participating in the study - Feeling the need for support to cope with the loss (a diagnosis of complicated grief is not necessary) - Age: 18 years or older - Regular Internet access - Mastery of the French language - Approved ICF Exclusion Criteria: - Moderate to acute current suicidality (SIDAS > 19) - Severe psychological or somatic disorders which need immediate treatment. - Concomitant psychotherapy - Prescription or change in dosage of psychoactive drugs in the month prior or during the self-help intervention. - Inability to follow the procedures of the study, e.g. due to comprehension problems - Enrolment of the investigator, his/her family members, employees, and other dependent persons. |
Country | Name | City | State |
---|---|---|---|
Switzerland | University of Lausanne - Institute of Psychology | Lausanne | Vaud |
Lead Sponsor | Collaborator |
---|---|
Debrot Anik |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in complicated grief symptoms | assessed with a French version (Cherblanc & Zech, 2021) of The Traumatic Grief Inventory (Boelen et al., 2019), on a scale ranging from 1 = never to 5 = always. The mean score is used as a final score. Higher score represent a higher symptom load. | Pretest; 12-week post-test; 3-month Follow-up | |
Primary | Change in depression symptoms | assessed with the Patient Health Questionnaire-9 (Kroenke & Spitzer, 2002; Kroenke, Spitzer & Williams, 2001), on a scale ranging from 0 = never to 4 = practically every day. The sum of the scores is used as a final score. Higher score represent a higher symptom load. | Pretest; 12-week post-test; 3-month Follow-up | |
Primary | Change in well-being | measured with the French version (Villieux et al., 2016) of the Flourishing Scale (Diener et al., 2010), on a scale ranging from 1 = I completely disagree, to 7 = I completely agree. The mean score is used as a final score. Higher score represent a better psychological well-being. | Pretest; 12-week post-test; 3-month Follow-up | |
Secondary | Change in anxiety symptoms | assessed with the Generalized Anxiety Scale (Micoulaud-Franchi et al., 2016; Spitzer et al., 2006), on a scale ranging from 0 = never to 4 = practically every day. The sum of the scores is used as a final score. Higher score represent a higher symptom load. | Pretest; 12-week post-test; 3-month Follow-up | |
Secondary | Change in grief coping strategies | measured with the Coping with Bereavement Questionnaire (Ryckebosch-Dayez et al., 2016), on a scale ranging from 1 = almost never to 5 = always. Higher scores represent a higher use of the coping strategy. | Pretest; 12-week post-test; 3-month Follow-up | |
Secondary | Change in aspects related to identity | Measured with three scales:
The Self-Concept Clarity (Brunot et al., 2015; Campbell et al., 1996) has a scale ranging from 1 = I completely disagree to 5 = I completely agree. The mean score is used as a final score. Higher score represent a lesser clarity of the self-concept. The Centrality of Event Scale (Berntsen & Rubin, 2006; Ceschi et al., 2009) has a scale ranging from 1 = I completely disagree to 5 = I completely agree. The mean score is used as a final score. Higher score represent a higher centrality of the event of loss. Questions about self-continuity (Lampraki et al., 2019), on a scale ranging from 1 = does not suit me to 5 = suits me perfectly. The mean score is used as a final score. Higher score represent a higher self-continuity. |
Pretest; 12-week post-test; 3-month Follow-up | |
Secondary | Satisfaction with the program (utility, clarity, impact, etc.) assessed by an adapted version of the CSQ-I | The investigators will measure the satisfaction with the program, by using a translated and adapted version of the Client Satisfaction Questionnaire (CSQ-I; Boß et al., 2016) assessing different quantitative and qualitative questions. These questions will be evaluated separately. | 12-week post-test | |
Secondary | Change in the monitoring of the mood, solitude feelings and grief symptoms | The investigators will weekly monitor the mood of the participants of LIVIA 2 using a single item ("How would you describe your current mood" on a scale ranging from 0 (very bad) to 6 (very good). Moreover, the investigators will weekly monitor the grief and solitude symptoms on a scale ranging from 1 (strongly disagree) to 5 (strongly agree) with the following items: "During the past 24 hours: (1) I have felt negative emotions ; (2) I have had negative images or thoughts ; (3) I felt blocked in my behaviour (what I do, my activities) ; (4) I felt lonely ; (5) I felt like I had a clear sense of who I am and what I want in life. | Days 1, 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, 78, 85 | |
Secondary | Indicators of verbal immediacy (use of first-person pronouns and present tense words) and so-called "we-talk" (first-person plural pronouns) | The investigators will analyse the linguistic behaviours and the semantic content in the exercises where the participants are required to describe a situation related to the loss. The objective is to test if some semantic categories (e.g. "we-talk", Bourassa et al., 2018) are associated with the efficacy of the programme. | 12-week Post-test | |
Secondary | Degree of required guidance in each group | number of participants requiring guidance and number of e-mails exchanged | 12-week Post-test |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04552717 -
My Grief - an App for Parents With Prolonged Grief After Losing a Child to Cancer
|
N/A | |
Active, not recruiting |
NCT05026827 -
Iyengar Yoga for Prolonged Grief Disorder
|
N/A | |
Completed |
NCT05121792 -
Web Based Therapist Tutorial on Prolonged Grief
|
N/A | |
Completed |
NCT05575817 -
Web Based Patient Tutorial on Prolonged Grief
|
N/A | |
Withdrawn |
NCT01247025 -
Prolonged Grief and Suicide Among Veterans
|
N/A | |
Recruiting |
NCT04121884 -
Neurophysiological Mechanisms of Accelerated Resolution Therapy (ART)
|
N/A | |
Completed |
NCT04409821 -
Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care
|
N/A | |
Completed |
NCT04505904 -
Oxytocin and Approach-avoid in Grief
|
N/A | |
Withdrawn |
NCT03568955 -
Measurement and Assessment of Prolonged Grief Disorder in Asia
|
||
Terminated |
NCT04547985 -
Naltrexone Treatment for Prolonged Grief Disorder (PGD)
|
Phase 4 | |
Recruiting |
NCT05274841 -
Systematic Support for Relatives of Palliative Care Patients
|
N/A | |
Completed |
NCT01556048 -
Pilot Study of Behavioral Activation for Prolonged Grief
|
Phase 1 | |
Recruiting |
NCT04462146 -
An Internet-based Self Applied Treatment Program for Prolonged Grief Disorder (PGD)
|
N/A | |
Completed |
NCT02283333 -
Treatment of Prolonged Grief Disorder in Combat Veterans
|
N/A | |
Enrolling by invitation |
NCT06017765 -
Coping After Loss Through Mindfulness in Adults With Prolonged Grief Disorder
|
N/A | |
Recruiting |
NCT05365139 -
Diagnostic Tools for Identifying Prolonged Grief
|
||
Recruiting |
NCT00553956 -
A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Rwandan Genocide
|
Phase 1 | |
Recruiting |
NCT04694807 -
Cognitive Behavioural Therapy for Complicated Grief Reactions in Old Age
|
N/A |